TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/20 21:18 | 12/14/20 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Papkoff Jacqueline Sybil | CA | O | SVP-CSO | S | -8 | 6.15 | 0 | -1 | -3 | 37 | D | ||||||||||||||
3/31/20 16:16 | 3/30/20 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Papkoff Jacqueline Sybil | CA | O | SVP-CSO | S.d | -18 | 14.22 | 0 | -1 | -3 | 39 | D | ||||||||||||||
12/16/19 17:21 | 12/13/19 | ASMB | Assembly Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Papkoff Jacqueline Sybil | IN | O | SVP-CSO | S | -31 | 21.00 | 0 | -1 | -6 | 23 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |